Search

everythinglearnresearchcommunity

for

Search:↓

Type 3 5α-reductase is more common and finasteride and dutasteride strongly inhibit it.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Bolandiol, a synthetic steroid, builds muscle and bone without greatly affecting sex glands, and works differently from other hormones.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

We now understand more about what causes acne and this could lead to better, more personalized treatments.

Flutamide and its metabolite can effectively reduce androgen effects.

No cure for female pattern hair loss, but various effective treatments exist.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

Mechanical stress contributes to hair loss in androgenetic alopecia.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Bald men may have a lower risk of testicular cancer.

AGA might indicate higher risk for severe COVID-19.

Severe hair loss may increase the risk of dying from COVID-19.

Women with PCOS and androgenic alopecia have different triglyceride metabolism compared to those without hair loss.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Future acne treatments should aggressively target inflammation to prevent scarring.

Epitestosterone may counteract testosterone's effects and has roles in body processes like prostate growth and hair distribution.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Increased PPARGC1α relates to hair thinning in common baldness.

New A-homo-B, 19-dinor steroids showed strong antiandrogenic activity without affecting the enzyme 5α-reductase or androgen receptor binding.

The meeting presented new findings on hair stem cells, pigmentation, genetics, and modern hair treatment techniques.

Androgen levels are more linked to body size in boys than girls.

Hair steroid profiling is a feasible, non-invasive alternative to serum analysis for assessing hormone levels and metabolism.

Platelet-rich plasma therapy shows promise in treating hair loss caused by androgenic alopecia.

The patient likely has Chrousos syndrome, a rare condition causing insensitivity to glucocorticoids, requiring high-dose dexamethasone treatment.

Alopecia areata incognita causes sudden hair thinning, responds well to steroids, and is more common in those with genetic hair loss conditions.

Polycystic ovary syndrome causes chronic inflammation affecting all body systems, but proper nutrition, exercise, and supplements can improve the condition.

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.